Development and In Vitro Evaluation of Alginate Gel–Encapsulated, Chitosan-Coated Ceramic Nanocores for Oral Delivery of Enzyme

REFERENCES

• Barret A. Peptidases: A view of classification and nomenclature. Proteases: A new perspective, V. Turk. Birkhauser Verlag, BaselSwitzerland 1991; 1–56
   Google Scholar
• Cherian A. K., Rana A. C., Jain S. K. Self-assembled carbohydrate-stabilized ceramic nanoparticles for the parenteral delivery of insulin. Drug. Dev. Ind. Pharm. 2000; 26(4)459–463
   PubMed Web of Science ®Google Scholar
• Cleland J. L. Protein delivery from biodegradable microspheres. Protein delivery: Physical systems, L. M Sander, R. W. Hendren. Plenum Press, New York 1977; 1–43
   Google Scholar
• Conradi R. A., Hilghers A. R., Ho N. F. H., Burton P. S. The influence of peptide structure on transport across Caco-2 cells: II. Peptide bond modification, which results in improved permeability. Pharm. Res. 1992; 9: 435–439
   PubMed Web of Science ®Google Scholar
• Coppi G., Iannuccelli V., Leo E., Bernabei M. T., Cameroni R. Protein immobilization in crosslinked alginate microparticles. J. Microencapsulation. 2002; 19(1)37–44
   PubMed Web of Science ®Google Scholar
• De S., Robinson D. Polymer relationships during preparation of chitosan- alginate and poly-l-lysine–alginate nanospheres. J. Control. Release. 2003; 89: 101–112
   PubMed Web of Science ®Google Scholar
• Dredan J., Antal I., Racz I. Evaluation of mathematical models describing drug release from lipophilic matrices. Int. J. Pharm. 1996; 145: 61–64
   Web of Science ®Google Scholar
• Garcia-Fuentes M., Torres D., Alonso M. J. New surface modified lipid nanoparticles as delivery vehicles for salmon calcitonin. Int. J. Pharm. 2005; 296: 122–132
   PubMed Web of Science ®Google Scholar
• Gibaldi M., Perrier D. Pharmacokinetics2nd. Marcel Dekker, New York 1982
   Google Scholar
• Gombotz W. R., Wee S. F. Protein release from alginate matrices. Adv. Drug Del. Rev. 1998; 31: 267–285
   PubMed Web of Science ®Google Scholar
• Janes K. A., Calvo P., Alonso M. J. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Delivery Rev. 2001; 47: 83–97
   PubMed Web of Science ®Google Scholar
• Kawashima Y., Yamamoto H., Takeuchi H., Kuno Y. Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of calcitonin. Pharmaceutic. Develop. Technol. 2000; 5: 77–85
   PubMed Web of Science ®Google Scholar
• Kee W. H., Tan S. L., Lee V., Salmon Y. M. The treatment of breast engorgement with serrapeptase: A randomized double blind controlled trial. Singapore Med J. 1989; 30(1)48–54
   PubMedGoogle Scholar
• Knaul J. Z., Hudson S. M., Creber K. A. M. Improved mechanical properties of chitosan fibers. J. Appl. Polym. Sci. 1999; 72: 1721–1731
   Web of Science ®Google Scholar
• Kossovsky N., Bunshah R. F., Gelman A., Sponsler E., Umarjee D. M., Suh T. G., et al. A non-denaturing solid phase pharmaceutical carrier comprised of surface-modified nanocrystalline materials. J. Appl. Biomater. 1990; 1: 289–294
   PubMedGoogle Scholar
• Kossovsky N., Gelman A., Rajguru S., Nguyen R., Sponsler E., Hnatyszyn H. J., et al. Control of molecular polymorphisms by a structured carbohydrate/ceramic delivery vehicle—Aquasomes. J. Control. Release. 1996; 39: 383–388
   Web of Science ®Google Scholar
• Lameiro M. H., Lopes A., Martins L. O., Alves P. M., Meloa E. Incorporation of a model protein into chitosan–bile salt microparticles. Int. J. Pharm. 2006; 312: 119–130
   PubMed Web of Science ®Google Scholar
• Loukas Y. L., Gregoriadis G. Novel liposome based systems for the protection of labile drugs. Proc. Int. Symp. Controlled Release Bioact. Mater. 1997; 24(104)204
   Google Scholar
• Majima Y., Hirata K., Takeuchi K., Hattori M., Sakakura Y. Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus. Am. Rev. Respir. Dis. January, 1990; 141(1)79–83
   PubMed Web of Science ®Google Scholar
• Morimoto K., Yamaguchi H., Iwakura Y., Miyazaki M., Nakatami E., Iwamoto T., et al. Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue. Pharm. Res. 1991; 8: 1175–1179
   PubMed Web of Science ®Google Scholar
• Ostberg T., Lund E. M., Graffner C. Calcium alginate matrices for oral multiple unit administration: IV release characteristics in different media. Int. J. Pharm. 1994; 112: 241–248
   Web of Science ®Google Scholar
• Paul W., Sharma C. P. Porous hydroxyapatite nanoparticles for intestinal delivery of insulin. Trends Biomat. Art. Organs. 2001; 14(2)37–38
   Google Scholar
• Peppas N. A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta. Helv. 1985; 60: 110–111
   PubMedGoogle Scholar
• Prokop A., Kozlov E., Newman G. W., Newman M. J. Water based nanoparticulate polymeric system for protein delivery: Permeability control and vaccine application. Biotechnol. Bioeng. 2002; 78: 459–466
   PubMed Web of Science ®Google Scholar
• Rawat M., Singh D., Saraf S., Saraf S. Nanocarriers: Promising vehicle for bioactive drugs. Biol. Pharm. Bull. 2006; 29(9)1790–1798
   PubMed Web of Science ®Google Scholar
• Salamone P. R., Wodzinski R. J. Production, purification and characterization of a 50-kDa extracellular metalloprotease from Serratia marcescens. Appl. Microbiol. Biotechnol. 1997; 48: 317–324
   PubMed Web of Science ®Google Scholar
• Shah M., Paradkar A. Cubic liquid crystalline glyceryl monooleate matrices for oral enzyme delivery. Int. J. Pharm. 2005; 294: 161–171
   PubMed Web of Science ®Google Scholar
• Shargel L., Yu A. Applied biopharmaceutics and pharmacokinetics4th. Prentice Hall, London 1999
   Google Scholar
• Siepmann J., Peppas N. A. Modelling of drug release from delivery systems based on hydroxypropyl methyl cellulose (HPMC). Adv. Drug Del. Rev. 2001; 48: 139–157
   PubMed Web of Science ®Google Scholar
• Taqieddin E., Lee C., Amiji M. Permselective chitosan of hybrid microcapsules for enzyme immobilization. Pharm. Eng. 2002; 22(6)1–3
   Google Scholar
• Torchilin V. P., Tischenko E. G., Smirnov V. N., Chazov E. I. Immobilization of enzymes on slowly soluble carriers. J. Biomed. Mater. Res. 1977; 11: 223–235
   PubMed Web of Science ®Google Scholar
• Yu J. H., Du Y. M., Zheng H. Blend films of chitosan*/gelation. J. Wuhan Univ. (Nat. Sci. Ed.). 1999; 45: 440–444
   Google Scholar
• Zhou X. H. Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugs. J. Control. Release. 1994; 29: 239–252
   Web of Science ®Google Scholar
• Zhou S., Deng X., Li X. Investigation on a novel core coated microspheres protein delivery system. J. Control. Release. 2001; 75: 27–36
   PubMed Web of Science ®Google Scholar
• Zhou X. H., Li W. P. Comparison of enzyme activities of tissues lining portals of absorption of drugs: Species differences. Int. J. Pharm. 1991a; 70: 271–283
   Google Scholar
• Zhou X. H., Li W. P. Peptide and protein drugs: I. Therapeutic applications, absorption and parenteral administration. Int. J. Pharm. 1991b; 75: 97–115
   Web of Science ®Google Scholar